Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis

dc.contributor.authorDu Plessis, Tamarisk
dc.contributor.authorRae, William Ian Duncombe
dc.contributor.authorRamkilawon, Gopika Devi
dc.contributor.authorRamkilawon, Gopika Devi
dc.contributor.authorMartinson, Neil Alexander
dc.contributor.authorSathekge, Mike Machaba
dc.date.accessioned2024-05-15T12:16:40Z
dc.date.available2024-05-15T12:16:40Z
dc.date.issued2023-09-01
dc.descriptionDATA AVAILABILITY STATEMENT : Data are available on request from the corresponding author.en_US
dc.description.abstractTuberculosis (TB) remains the second leading cause of death globally from a single infectious agent, and there is a critical need to develop improved imaging biomarkers and aid rapid assessments of responses to therapy. We aimed to utilize radiomics, a rapidly developing image analysis tool, to develop a scoring system for this purpose. A chest X-ray radiomics score (RadScore) was developed by implementing a unique segmentation method, followed by feature extraction and parameter map construction. Signature parameter maps that showed a high correlation to lung pathology were consolidated into four frequency bins to obtain the RadScore. A clinical score (TBscore) and a radiological score (RLscore) were also developed based on existing scoring algorithms. The correlation between the change in the three scores, calculated from serial X-rays taken while patients received TB therapy, was evaluated using Spearman’s correlation. Poor correlations were observed between the changes in the TBscore and the RLscore (0.09 (p-value = 0.36)) and the TBscore and the RadScore (0.02 (p-value = 0.86)). The changes in the RLscore and the RadScore had a much stronger correlation of 0.22, which is statistically significant (p-value = 0.02). This shows that the developed RadScore has the potential to be a quantitative monitoring tool for responses to therapy.en_US
dc.description.departmentNuclear Medicineen_US
dc.description.departmentStatisticsen_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipFUNDING : The APC was funded by the Department of Nuclear Medicine, University of Pretoria, South Africa.en_US
dc.description.urihttps://www.mdpi.com/journal/diagnosticsen_US
dc.identifier.citationDu Plessis, T.; Rae, W.I.D.; Ramkilawon, G.; Martinson, N.A.; Sathekge, M.M. Quantitative Chest X-ray Radiomics for Therapy Response Monitoring in Patients with Pulmonary Tuberculosis. Diagnostics 2023, 13, 2842. https://DOI.org/10.3390/diagnostics13172842.en_US
dc.identifier.issn2075-4418 (online)
dc.identifier.other10.3390/diagnostics13172842
dc.identifier.urihttp://hdl.handle.net/2263/95995
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_US
dc.subjectRadiomicsen_US
dc.subjectSegmentationen_US
dc.subjectFeature extractionen_US
dc.subjectChest X-raysen_US
dc.subjectRadiomics scoreen_US
dc.subjectTuberculosis (TB)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleQuantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosisen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DuPlessis_Quantitative_2023.pdf
Size:
3.39 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: